第一单位：
Respiratory Pharmacology Group, Airway Disease, National Heart & Lung Institute, Imperial College London, London, United Kingdom; MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
作者：
Ryan K,Robinson [1]
;
Mark A,Birrell [1]
;
John J,Adcock [2]
;
Michael A,Wortley [2]
;
Eric D,Dubuis [2]
;
Shu,Chen [3]
;
Catriona M,McGilvery [3]
;
Sheng,Hu [4]
;
Milo S P,Shaffer [5]
;
Sara J,Bonvini [2]
;
Sarah A,Maher [2]
;
Ian S,Mudway [6]
;
Alexandra E,Porter [7]
;
Chris,Carlsten [8]
;
Teresa D,Tetley [9]
;
Maria G,Belvisi [10]
作者单位：
Respiratory Pharmacology Group, Airway Disease, National Heart & Lung Institute, Imperial College London, London, United Kingdom; MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
[1]
Respiratory Pharmacology Group, Airway Disease, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
[2]
Department of Materials and London Centre for Nanotechnology, Imperial College London, London, United Kingdom.
[3]
Department of Chemistry and London Centre for Nanotechnology, Imperial College London, London, United Kingdom.
[4]
Department of Materials and London Centre for Nanotechnology, Imperial College London, London, United Kingdom; Department of Chemistry and London Centre for Nanotechnology, Imperial College London, London, United Kingdom.
[5]
MRC-PHE Centre for Environment and Health, King's College London, London, United Kingdom; NIHR Health Protection Research Unit in Health Impact of Environmental Hazards, London, United Kingdom.
[6]
Department of Materials and London Centre for Nanotechnology, Imperial College London, London, United Kingdom; NIHR Health Protection Research Unit in Health Impact of Environmental Hazards, London, United Kingdom.
[7]
Centre for Heart Lung Innovation, University of British Columbia, Vancouver, British Columbia, Canada.
[8]
NIHR Health Protection Research Unit in Health Impact of Environmental Hazards, London, United Kingdom; Lung Cell Biology, Airways Disease, National Heart & Lung Institute, Imperial College London, London, United Kingdom. Electronic address: t.tetley@imperial.ac.uk.
[9]
Respiratory Pharmacology Group, Airway Disease, National Heart & Lung Institute, Imperial College London, London, United Kingdom; MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom. Electronic address: m.belvisi@imperial.ac.uk.
[10]
DOI
10.1016/j.jaci.2017.04.038
PMID
28532657
发布时间
2025-05-30
换一批
